BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31014918)

  • 1. MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases.
    Ge Y; Sun M; Wu W; Ma C; Zhang C; He C; Li J; Cong Y; Zhang D; Liu Z
    J Autoimmun; 2019 Jul; 101():109-120. PubMed ID: 31014918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
    Nie J; Zhao Q
    Front Immunol; 2020; 11():852. PubMed ID: 32547537
    [No Abstract]   [Full Text] [Related]  

  • 3. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
    He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
    Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease.
    Shi Y; Dai S; Qiu C; Wang T; Zhou Y; Xue C; Yao J; Xu Y
    Mucosal Immunol; 2020 Mar; 13(2):303-312. PubMed ID: 31628427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP.
    He Q; Gao H; Chang YL; Wu X; Lin R; Li G; Lin J; Lu H; Chen H; Li Z; Cong Y; Yao J; Liu Z
    J Autoimmun; 2022 Oct; 132():102872. PubMed ID: 35926374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting T
    Zhou G; Wu W; Yu L; Yu T; Yang W; Wang P; Zhang X; Cong Y; Liu Z
    J Allergy Clin Immunol; 2018 Oct; 142(4):1218-1228.e12. PubMed ID: 29113905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1/STAT3 in psoriasis.
    Yan K; Zhang F; Ren J; Huang Q; Yawalkar N; Han L
    J Transl Med; 2023 Sep; 21(1):678. PubMed ID: 37773129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of ROCK2 activity in facilitating mucosal CD4
    Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z
    J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5.
    Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
    Wu W; He C; Liu C; Cao AT; Xue X; Evans-Marin HL; Sun M; Fang L; Yao S; Pinchuk IV; Powell DW; Liu Z; Cong Y
    Gut; 2015 Nov; 64(11):1755-64. PubMed ID: 25281418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.
    Holmkvist P; Pool L; Hägerbrand K; Agace WW; Rivollier A
    Eur J Immunol; 2016 Jun; 46(6):1371-82. PubMed ID: 27062602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR65 promotes intestinal mucosal Th1 and Th17 cell differentiation and gut inflammation through downregulating NUAK2.
    Lin R; Wu W; Chen H; Gao H; Wu X; Li G; He Q; Lu H; Sun M; Liu Z
    Clin Transl Med; 2022 Mar; 12(3):e771. PubMed ID: 35343079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOB1 Blocks Intestinal Mucosal Inflammation Through Inducing ID2-Mediated Suppression of Th1/Th17 Cell Immune Responses in IBD.
    Lin R; Ma C; Fang L; Xu C; Zhang C; Wu X; Wu W; Zhu R; Cong Y; Liu Z
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1201-1221. PubMed ID: 34920145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
    Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
    Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease.
    Yang X; He Q; Guo Z; Xiong F; Li Y; Pan Y; Gao C; Li L; He C
    Biochem Biophys Res Commun; 2018 Feb; 496(2):352-358. PubMed ID: 29331376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF5 regulates intestinal mucosal Th1/Th17 cell immune responses via Runx1 in colitis mice.
    Li M; Gan C; Zhang R; Wang J; Wang Y; Zhu W; Liu L; Shang J; Zhao Q
    Immunology; 2023 Dec; 170(4):495-509. PubMed ID: 37575027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.
    Bregenholt S; Brimnes J; Nissen MH; Claesson MH
    Clin Exp Immunol; 1999 Nov; 118(2):228-34. PubMed ID: 10540183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.